These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 16956438)
1. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis. Brunner J; Sitzmann FC Clin Exp Rheumatol; 2006; 24(4):449-51. PubMed ID: 16956438 [TBL] [Abstract][Full Text] [Related]
2. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype. Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667 [TBL] [Abstract][Full Text] [Related]
3. Anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Brunner JK; Sitzmann FC Mod Rheumatol; 2006; 16(6):372-5. PubMed ID: 17164999 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients. Spârchez M; Miu N; Bolba C; Iancu M; Spârchez Z; Rednic S Clin Rheumatol; 2016 Mar; 35(3):601-7. PubMed ID: 25994613 [TBL] [Abstract][Full Text] [Related]
5. Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA). Lipinska J; Lipinska S; Kasielski M; Smolewska E Clin Rheumatol; 2016 Nov; 35(11):2699-2706. PubMed ID: 27457366 [TBL] [Abstract][Full Text] [Related]
6. Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis. Moore TL; Gillian BE; Crespo-Pagnussat S; Feller L; Chauhan AK Clin Exp Rheumatol; 2014; 32(5):740-6. PubMed ID: 25068682 [TBL] [Abstract][Full Text] [Related]
7. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508 [TBL] [Abstract][Full Text] [Related]
8. Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population. Kwok JS; Hui KH; Lee TL; Wong W; Lau YL; Wong RW; Kim DL; Jones BM Scand J Rheumatol; 2005; 34(5):359-66. PubMed ID: 16234183 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis. Pang SY; Liu HY; Huang YJ; Liu YF; Dai YM; Zeng P; Zeng HS Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323035 [TBL] [Abstract][Full Text] [Related]
11. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. van Rossum M; van Soesbergen R; de Kort S; ten Cate R; Zwinderman AH; de Jong B; Dijkmans B; van Venrooij WJ J Rheumatol; 2003 Apr; 30(4):825-8. PubMed ID: 12672206 [TBL] [Abstract][Full Text] [Related]
13. [Antibodies to mutated citrullinated vimentin and some associated autoantibodies in juvenile idiopathic arthritis]. Zhang L; Ru J; Jie X; Che G; Jin X; Li X Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):948-51. PubMed ID: 26887552 [TBL] [Abstract][Full Text] [Related]
14. Limitations in the classification of childhood-onset rheumatoid arthritis. Ferrell EG; Ponder LA; Minor LS; Angeles-Han ST; Kennedy CW; Rouster-Stevens KA; Rohani-Pichavant M; Vogler LB; Prahalad S J Rheumatol; 2014 Mar; 41(3):547-53. PubMed ID: 24488421 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Kasapçopur O; Altun S; Aslan M; Karaarslan S; Kamburoglu-Göksel A; Saribas S; Arisoy N; Kocazeybek B Ann Rheum Dis; 2004 Dec; 63(12):1687-9. PubMed ID: 15547097 [TBL] [Abstract][Full Text] [Related]
16. Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis. Kuna AT; Lamot L; Miler M; Harjacek M; Simundic AM; Vrkic N Clin Chem Lab Med; 2009; 47(12):1525-30. PubMed ID: 19842993 [TBL] [Abstract][Full Text] [Related]
17. Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial). Omar A; Abo-Elyoun I; Hussein H; Nabih M; Atwa H; Gad S; Emad Y Joint Bone Spine; 2013 Jan; 80(1):38-43. PubMed ID: 22575064 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Avcin T; Cimaz R; Falcini F; Zulian F; Martini G; Simonini G; Porenta-Besic V; Cecchini G; Borghi MO; Meroni PL Ann Rheum Dis; 2002 Jul; 61(7):608-11. PubMed ID: 12079901 [TBL] [Abstract][Full Text] [Related]
19. Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA). Berntson L; Nordal E; Fasth A; Aalto K; Herlin T; Nielsen S; Rygg M; Zak M; Rönnelid J; Pediatr Rheumatol Online J; 2014; 12():22. PubMed ID: 24944545 [TBL] [Abstract][Full Text] [Related]
20. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis. Dewint P; Hoffman IE; Rogge S; Joos R; Union A; Dehoorne J; Delanghe J; Veys EM; De Keyser F; Elewaut D Rheumatology (Oxford); 2006 Feb; 45(2):204-8. PubMed ID: 16188943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]